Board of Directors

Helen S. Kim

Board Chairman

Helen S. Kim, M.B.A., joined our board of directors in August 2018, bringing with her over 27 years of leadership experience in biotechnology. Ms. Kim currently serves as managing director of Vida Ventures, a position she has held since April 2019. From March 2018 to March 2019, Ms. Kim served as a partner at The Column | READ MORE

Graham K. Cooper


Graham K. Cooper has served as a member of our board of directors since January 2020.  From March 2018 until May 2019, Mr. Cooper served as the Chief Operating Officer and Chief Financial Officer of Assembly Biosciences, Inc. Mr. Cooper previously served as the Chief Financial Officer of Receptos, Inc., from February 2013 until its acquisition | READ MORE

David Lamond


David A. Lamond joined our board of directors in September 2018. Since April 2016, Mr. Lamond has served as president of En Pointe LLC, an investment firm. From 2011 to 2016, he served as the president, chief executive officer and chief investment officer of Lamond Capital Partners LLC. | READ MORE

Tahir Mahmood, PhD


Tahir co-founded AMT, where he has overseen the company’s growth from concept to clinical trials in patients through multiple equity financing rounds. He was closely involved in the early development of the technology and also led the company’s partnering and corporate development activities. | READ MORE

Randall Mrsny, PhD


An epithelial biologist, Randy has more than three decades of industry and academic experience in pharmaceutical sciences and research into the mucosal trafficking of peptide and protein therapeutics.  | READ MORE

Aaron VanDevender


Aaron VanDevender, Ph.D., joined our board of directors in November 2016. Since 2012, Dr. VanDevender has served as chief scientist and principal at Founders Fund.  From October 2010 to March 2012, Dr. VanDevender served as a physicist at Halcyon Molecular, a company focused on next-generation DNA sequencing technology. | READ MORE